Bull case
LRCX would need investors to value it at roughly 124x earnings — about 75x more generous than today's 49x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
Wall Street verdict, consensus price target, and analyst rating breakdown — everything needed to frame the risk/reward at today's price.
Three scenarios for where LRCX stock could go
LRCX would need investors to value it at roughly 124x earnings — about 75x more generous than today's 49x forward P/E. That requires meaningful multiple expansion on top of continued earnings growth.
At 89x on FY1 earnings, the base case reflects a reasonable but not stretched valuation. It prices in continued growth without assuming an exceptional setup.
If investor confidence fades or macro conditions deteriorate, a 16x multiple contraction could push LRCX down roughly 33% from where it trades now.
Not financial advice. Model confidence reflects internal scenario assumptions, not a guarantee of returns. Past performance does not predict future results.

Lam Research is a leading manufacturer of semiconductor fabrication equipment used to produce integrated circuits. The company generates revenue primarily from selling wafer fabrication equipment — including etch, deposition, and cleaning systems — and related services, with equipment sales typically representing around 80% of total revenue. Its competitive advantage stems from deep process expertise in critical semiconductor manufacturing steps, particularly in etch and deposition technologies where it holds strong market positions.
Quarterly beat-or-miss track record against analyst estimates, plus forward revenue and EPS outlook for the next two fiscal years.
| Quarter | EPS (Actual / Est) | EPS Surprise | Revenue (Actual / Est) | Rev Surprise |
|---|---|---|---|---|
| Q3 2025 | $1.33/$1.21 | +9.9% | $5.2B/$5.0B | +3.3% |
| Q4 2025 | $1.26/$1.22 | +3.3% | $5.3B/$5.2B | +1.9% |
| Q1 2026 | $1.27/$1.17 | +8.5% | $5.3B/$5.2B | +2.1% |
| Q2 2026 | $1.47/$1.36 | +8.1% | $5.8B/$5.8B | +1.6% |
LRCX beat EPS estimates in 4 of 4 tracked quarters. A perfect track record raises the bar for the upcoming report.
Product and geographic revenue mix from the latest annual disclosure, with year-over-year growth by segment.
Latest annual revenue by segment or product family
Tap, hover, or focus a slice to inspect segment detail.
Latest annual revenue by reported region
Tap, hover, or focus a slice to inspect segment detail.
Current multiples compared to the S&P 500, the company's sector, and its own five-year average.
Fair value est. $176 — implies -31.3% from today's price.
| Metric | LRCX | S&P 500 | Technology | 5Y Avg LRCX |
|---|---|---|---|---|
| Forward PE | 48.8x | 19.1x+156% | 22.1x+120% | — |
| Trailing PE | 66.5x | 25.1x+165% | 26.7x+149% | 23.1x+187% |
| PEG Ratio | 2.97x | 1.72x+73% | 1.52x+95% | — |
| EV/EBITDA | 54.5x | 15.2x+258% | 17.5x+212% | 19.1x+186% |
| Price/FCF | 63.6x | 21.1x+202% | 19.5x+226% | 25.4x+151% |
| Price/Sales | 18.7x | 3.1x+498% | 2.4x+665% | 6.2x+202% |
| Dividend Yield | 0.32% | 1.87% | 1.16% | 0.96% |
Forward P/E and PEG reflect analyst consensus estimates. Historical averages use trailing ratios where forward data is unavailable.S&P 500 and sector benchmarks both use trailing median P/E — similar readings indicate the broader index and sector are priced alike.
Open valuation toolLRCX generates $6.5B in free cash flow at a 29.8% margin — 55.7% ROIC signals a durable competitive advantage · returns 1.3% of market cap to shareholders annually.
Revenue, margins, and cash generation
ROIC, leverage, and debt serviceability
How capital is returned to owners
All figures from the trailing twelve months. ROIC uses invested capital (equity + net debt).
Open full ratios pageKey factors that could pressure the stock price, compress the multiple, or weigh on future results.
AI analysis · updated April 11, 2026
Lam Research projects a sequential decline in gross margin to 48.5% ±1% for the December 2025 quarter, potentially triggering multiple compression if peak margins are perceived to be in the past. This is driven by an unfavorable product mix and tariff pressures, which could erode profitability and valuation multiples.
China is expected to account for less than 30% of total revenues in 2026, yet geopolitical tensions and U.S. export controls pose a risk of revenue disruption. A sudden restriction could lead to a de‑rating of the company’s valuation multiple and earnings volatility.
Elevated Days Inventory Outstanding signals potential excess inventory and channel stuffing, which could result in revenue and earnings losses if current sales are drawn from future demand. Inventory write‑downs or a slowdown in new orders could trigger significant stock price drops.
Lam Research’s revenue is heavily tied to the cyclical semiconductor industry, making it sensitive to demand swings and economic conditions. A chip cycle downturn could reduce customer capital spending and constrain growth.
The company must continuously innovate to stay competitive; failure to launch new products or improve existing ones could erode market share and lead to inventory obsolescence. Intense rivalry from well‑capitalized competitors adds pressure on margins.
Lam serves major semiconductor manufacturers, so a significant cut in capital spending by any key customer could materially impact quarterly results. Concentration amplifies revenue volatility.
These are risk mechanisms, not predictions. The key question is which would force a cut to earnings estimates or a lower multiple than the market currently prices in.
Structural drivers behind the upside case and why the stock could outperform over the next 12 months.
AI analysis · updated April 11, 2026
The surge in AI workloads and advanced chip architectures is a key catalyst, driving higher demand for wafer fabrication equipment (WFE). Lam Research’s order visibility has risen as it supplies critical tools for AI‑focused chip manufacturing and high‑bandwidth memory (HBM) production.
Lam Research is benefiting from robust growth in the memory chip market, with significant increases in DRAM revenue and services revenue. The company has expanded its share of the global WFE market over the past decade, reinforcing its position in memory production.
Lam Research holds defensible technologies and process leadership in areas such as ALD Moly and advanced packaging. Its collaboration with IBM on sub‑1 nm logic scaling further cements its leading edge in process technology.
Earnings are projected to grow significantly, with revenue and earnings estimates showing strong increases in the coming years. The company has demonstrated strong earnings growth over the past year and has a history of increasing its dividend.
A real bull case compounds — each driver matters most when it strengthens margins, supports capital returns, and keeps the company above the market's minimum growth bar simultaneously.
52-week range context and price returns across multiple time horizons. Dividend contribution is shown separately in the Capital Return section.
Range context matters because valuation compression and earnings misses rarely hit from the same starting point. A stock already far below its high can still fall, but it is no longer carrying the same embedded optimism as one pressing a fresh peak.
Valuation, growth, and margin comparison against the closest publicly traded peers for this company.
| Company | Mkt Cap | Fwd PE | Rev Grw | Margin | Rating | Upside |
|---|---|---|---|---|---|---|
LRC LRCX Lam Research Corporation | $344.4B | 48.8x | +9.6% | 30.9% | Buy | +5.4% |
AMA AMAT Applied Materials, Inc. | $325.8B | 37.1x | +8.9% | 24.7% | Buy | +3.8% |
KLA KLAC KLA Corporation | $227.7B | 47.1x | +9.4% | 35.7% | Buy | +5.0% |
ASM ASML ASML Holding N.V. | $560.1B | 44.6x | +22.3% | 29.4% | Buy | +10.6% |
TER TER Teradyne, Inc. | $55.9B | 49.5x | +10.6% | 22.6% | Buy | -1.7% |
ONT ONTO Onto Innovation Inc. | $15.2B | 43.1x | +20.6% | 10.3% | Buy | +1.1% |
This peer comparison reflects companies with similar business models, product lines, or market positioning, supplemented by industry grouping when direct matches are limited.
LRCX returns capital mainly through $3.4B/year in buybacks (1.0% buyback yield), with a modest 0.32% dividend — combining for 1.3% total shareholder yield. The dividend has grown for 11 consecutive years.
Yield, cadence, and growth quality
How much per-share support comes from repurchases
| Year | Div / Share | YoY Grw | BB Yield | Total Yield |
|---|---|---|---|---|
| 2026 | $0.26 | — | — | — |
| 2025 | $0.98 | +14.0% | 2.7% | 3.6% |
| 2024 | $0.86 | +15.4% | 2.0% | 2.7% |
| 2023 | $0.74 | +15.5% | 2.4% | 3.5% |
| 2022 | $0.65 | +15.2% | 6.1% | 7.4% |
Common questions answered from live analyst data and company financials.
Lam Research Corporation (LRCX) is rated Buy by Wall Street analysts as of 2026. Of 50 analysts covering the stock, 38 rate it Buy or Strong Buy, 11 rate it Hold, and 1 rate it Sell or Strong Sell. The consensus 12-month price target is $291, implying +5.4% from the current price of $276. The bear case scenario is $184 and the bull case is $699.
The Wall Street consensus price target for LRCX is $291 based on 50 analyst estimates. The high-end target is $385 (+39.6% from today), and the low-end target is $200 (-27.5%). The base case model target is $505.
LRCX trades at 48.8x times forward earnings. The stock trades at a notable premium to the broad market, which is typical for businesses with strong free cash flow and above-average growth expectations. Based on current multiples versus the peer group, the relative model signals significantly overvalued. Whether the stock is over or undervalued ultimately depends on whether consensus earnings estimates are achievable.
The primary risks for LRCX in 2026 are: (1) Margin Compression — Lam Research projects a sequential decline in gross margin to 48. (2) China Revenue Concentration — China is expected to account for less than 30% of total revenues in 2026, yet geopolitical tensions and U. (3) Excess Inventory & Channel Stuffing — Elevated Days Inventory Outstanding signals potential excess inventory and channel stuffing, which could result in revenue and earnings losses if current sales are drawn from future demand. Each factor has the potential to pressure earnings or compress the stock's valuation multiple.
Analyst consensus estimates LRCX will report consensus revenue of $23.8B (+9.6% year-over-year) and EPS of $5.87 (+10.0% year-over-year) for the upcoming fiscal year. The following year, analysts project $29.5B in revenue.
A confirmed upcoming earnings date for LRCX is not yet available. Check the Earnings section above for the most recent quarterly report dates and forward estimates.
Lam Research Corporation (LRCX) generated $6.5B in free cash flow over the trailing twelve months — a free cash flow margin of 29.8%. LRCX returns capital to shareholders through dividends (0.3% yield) and share repurchases ($3.4B TTM).